E
N. Scalacci et al.
Letter
Synlett
Cantrell, A. S.; Hoberg, M.; Jaskunas, S. R.; Johansson, N. G.;
Jodon, C. L.; Kinnik, M. D.; Lind, P.; Morin, J. M.; Zhang, H.; Zhou,
X. X. J. Med. Chem. 1995, 38, 4929.
(16) 1-Arylpropargylamines were prepared according to previous
work: Castagnolo, D.; Armaroli, S.; Corelli, F.; Botta, M. Tetrahe-
dron: Asymmetry 2004, 15, 941.
(3) (a) Zav’yalov, S. I.; Dorofeeva, O. V.; Rumyantseva, E. E.;
Kulikova, L. B.; Ezhova, G. I.; Kravchenko, N. E.; Zavozin, A. G.
Pharm. Chem. J. 2001, 35, 105. (b) Singh, M. S.; Nandi, G. C.;
Chanda, T. RSC Adv. 2013, 3, 14183.
(17) Thompson, C. M.; Poole, J. L.; Cross, J. L.; Akritopoulou-Zanze, I.;
Djuric, S. W. Molecules 2011, 16, 9161.
(18) Aoyama, T.; Murata, S.; Arai, I.; Araki, N.; Takido, T.; Suzuki, Y.;
Kodomari, M. Tetrahedron 2006, 62, 3201.
(4) Hantzsch, A.; Weber, J. H. Ber. Dtsch. Chem. Ges. 1887, 20, 3118.
(5) Cook, A. H.; Heilbron, I.; MacDonald, S. F.; Mahadevan, A. P.
J. Chem. Soc. 1949, 1064.
(6) (a) Zhu, Y. P.; Yuan, J. J.; Zhao, Q.; Lian, M.; Gao, Q. H.; Liu, M. C.;
Yang, Y.; Wu, A. X. Tetrahedron 2012, 68, 173. (b) Xue, W. J.;
Zheng, K. L.; Li, H. Z.; Geo, F. F.; Wu, A. X. Tetrahedron Lett. 2014,
55, 4212. (c) Zhao, R.; Gove, S.; Sundeen, J. E.; Chen, B.-C. Tetra-
hedron Lett. 2001, 42, 210.
(7) Siddiqui, H. L.; Iqbal, A.; Ahmed, S.; Weaver, G. Molecules 2006,
11, 206.
(8) Karade, H.; Sathe, M.; Kaushik, M. P. Catal. Commun. 2007, 8,
741.
(9) Potewar, T. P.; Ingale, S. A.; Srinivasan, K. V. Tetrahedron 2007,
63, 11066.
(10) Das, B.; Reddy, S. V.; Ramu, R. J. Mol. Catal. A: Chem. 2006, 252,
235.
(11) Narender, M.; Somi Reddy, M.; Sridhar, R.; Nageswar, K.;
Nageswar, K.; Rama Rao, K. Tetrahedron Lett. 2005, 46, 7779.
(12) Castagnolo, D.; Pagano, M.; Bernardini, M.; Botta, M. Synlett
2009, 2093.
(13) (a) Chachignon, H.; Scalacci, N.; Petricci, E.; Castagnolo, D. J. Org.
Chem. 2015, 80, 5287. (b) Castagnolo, D.; Dessì, F.; Radi, M.;
Botta, M. Tetrahedron: Asymmetry 2007, 11, 1345.
(c) Castagnolo, D.; Giorgi, G.; Spinosa, R.; Corelli, F.; Botta, M.
Eur. J. Org. Chem. 2007, 22, 3676.
(19) Ranjan, A.; Yerande, R.; Wakchaure, P. B.; Yerande, S. G.; Dethe,
D. H. Org. Lett. 2014, 16, 5788.
(20) General Procedure for the Synthesis of 2-Aminothiazoles 4
and 2-Amino-4-methylenethiazolines 5
Propargylamine 1a–e (1.0 mmol) and the appropriate isothio-
cyanate 2a–c (1.0 mmol) were suspended in an appropriate
solvent (DCE, MeCN, DMF, 1.0 mL) in a 10 mL glass vial
equipped with a small magnetic stirring bar. PTSA (0.5 mmol)
was then added to this solution, and the mixture was irradiated
under microwave conditions at the appropriate temperature
(see Tables 1 and 2) for 2 × 5 min, using an irradiation power of
300 W. The mixture was then poured into NaHCO3 solution (10
mL) and then extracted with EtOAc (2 × 10 mL). The combined
organic phases were washed with brine, dried over Mg2SO4, fil-
tered, and concentrated under reduced pressure. The crude
products were purified by flash column chromatography (SiO2;
hexanes–EtOAc, 4:1), to yield the desired products as tan-
coloured oils.
(21) 2-Aminothiazole 4a
1H NMR (400 MHz, CDCl3): δ = 6.67 (s, 1 H), 5.95–5.85 (m, 1 H),
5.79 (br s, 1 H), 5.30–5.25 (d, 1 H, J = 20 MHz), 5.17–5.14 (d, 1 H,
J = 12 MHz), 3.82 (d, 2 H, J = 4 MHz), 2.25 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 169.0, 135.5, 134.1, 121.1, 116.8, 48.2,
12.0 ppm. ESI-MS: m/z = 155 [M + H]+, 177 [M + Na]+.
(22) 2-Amino-4-methylenethiazoline 5a
(14) (a) Easton, N. R.; Cassady, D. R.; Dillard, R. D. J. Org. Chem. 1964,
29, 1851. (b) Eloy, F.; Deryckere, A. Chim. Ther. 1973, 4, 437.
(15) Viart, H. M.-F.; Larsen, T. S.; Tassone, C.; Andresen, T. L.; Clausen,
M. H. Chem. Commun. 2014, 50, 7800.
1H NMR (400 MHz, CDCl3): δ = 5.92–5.83 (m, 1 H), 5.24–5.19 (d,
1 H, J = 20 MHz), 5.14–5.08 (m, 3 H), 4.68 (m, 2 H), 3.89–3.88 (d,
2 H, J = 4 MHz) ppm. 13C NMR (100 MHz, CDCl3): δ = 158.3,
148.8, 134.3, 116.5, 102.5, 67.0, 46.6 ppm. ESI-MS: m/z = 155
[M + H]+, 177 [M + Na]+.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, A–E